Signals
Oral SERDs Face the Hard Test: Where Do They Actually Fit?
ASCO 2026 giredestrant updates show why oral SERDs remain promising in ER-positive breast cancer, but also why stage, sequence and resistance biology matter.
Digital Mental Health Still Has an Evidence Problem
Europe’s Mental Health Projects Move From Crisis Talk to Delivery Tools
Europe’s Epilepsy Rules Start Catching Up With Precision Treatment
SMA Screening Shows Precision Neurology Starts Before Symptoms
Post-Stroke Cognitive Screening Needs Local Tools
Europe’s Stroke Plan Turns Speed Into a Policy Test
Parkinson’s Research Moves From Tracking Progression to Defining Biology
MS Monitoring Starts Moving Beyond the MRI Bottleneck
Latin America Challenges the Dementia Biomarker Evidence Gap
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.